Dr Peter Lanyon is a Consultant Rheumatologist at Nottingham University Hospitals NHS Trust and a Past President of the British Society for Rheumatology. His clinical practice focuses on rare autoimmune diseases, working closely with ENT, Respiratory, and Renal colleagues to provide multidisciplinary care. His academic work encompasses clinical research, guideline development, and population-level studies aimed at improving patient outcomes and ensuring research directly informs NHS practice.

Dr Lanyon is the National Clinical Co-Lead for Rheumatology in the Getting It Right First Time (GIRFT) programme, an NHS England initiative designed to enhance patient care through service reviews, benchmarking, and data-driven recommendations. He also serves as Rare Diseases Clinical Lead for the National Disease Registration Service, NHS England.

He is a Board Member of the Rare Autoimmune Rheumatic Disease Alliance (RAIRDA), which brings together patient organisations to advocate for better care for those living with rare autoimmune rheumatic diseases in the UK.

Previously, he chaired the NHS England Clinical Reference Group for Specialised Rheumatology, overseeing the design, prioritisation, and implementation of commissioning policies to enable access to high-cost therapies.